Product Spotlight

What is Follistatin?

One of our hotter substances available for research purposes is Follistatin.  Follistatin is an Activin-binding protein.  Inherently available in humans, hard coded into our FST gene, we now can both harvest and manufacture Follistatin.  Paracrine signaling, or cell to cell communication, is the primary use case for Follistatin but not necessarily the only reason for its being.  Now, with a purity level of at least 98.81%, we guarantee you can be sure that you get every bit of what you’re paying for and stress on the details of your research rather than the quality or price of your solutions.

Follistatin Recognition

Follistatin is only something scientists and researchers have been aware of for a few years.  Prior to the completion of the human genome project, we could only speculate as to what piece of our genepool is responsible for communication between cells.  The National Institute of Health, the most respected and important child of the Department of Health and Human Services in regards to official research publication, has recognized Follistatin for its importance in protein coding in humans.  The NIH states “Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating hormone release.”

The outward NIH acceptance has led to a burst of new research projects, many of which have yet to be reviewed and published.  Over the past decade, specifically the last 5 years, the scientific community has made some interesting discoveries regarding the effects of enhanced Follistatin levels.

Follistatin Research

1987-1998 – First works completed regarding Follistatin.  Not exactly a home-run, but a team discovered and described a new gene piece of “follicle-stimulating hormone inhibiting substance present in ovarian follicular fluid.”  They named it Follistatin. The team in 1998 understood that follicle stimulation was just the beginning. It could be so much more.

1 NIH. “FST Follistatin [Homo Sapiens (Human)] – Gene – NCBI.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/gene/10468.

2 Phillips, D J, and D M de. “Follistatin: a Multifunctional Regulatory Protein.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Oct. 1998, www.ncbi.nlm.nih.gov/pubmed/9799587.

2001 – A real breakthrough!  Follistatin was discovered to play an important role in skin inflammation.  Recognizing that Follistatin was a building block for cellular alteration on a much later level increased research and further raised interest and speculation.

2009 – By the end of the decade, a team of American doctors had proven that Follistatin could be leveraged to inhibit muscle disease.  Now we’re really cookin’ with gas!

2014 – No longer just effective in muscle disease inhibition, it appears to be effective in all inflammatory disease inhibition.2018 – We’re now exploring the effects that offshoots of Follistatin will have on patients suffering from a variety of ailments.  

2018 – We’re now exploring the effects that offshoots of Follistatin will have on patients suffering from a variety of ailments.  

Subsequent Potential

Being the intelligent person that you are, you’ve likely already pieced together a few hypotheses regarding the future of Follistatin supplementation and probable use in the pharmaceutical industry.  Without understanding the full long-term side effects, Follistatin is not ready to be used on a large-scale medicinal operation. We need to know more about the different reactions Follistatin may have with a variety of common diseases, viruses, and medications.  The future is bright. If you want to be a part of it, get your Follistatin at gurupeptides.com today!

3 Kawakami, S, et al. “Follistatin Production by Skin Fibroblasts and Its Regulation by Dexamethasone.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, 14 Feb. 2001, www.ncbi.nlm.nih.gov/pubmed/11165049.

4 LOUISE R. RODINO-KLAPAC, AMANDA M. HAIDET, JANAIAH KOTA, CHALONDA HANDY, BRIAN K. KASPAR, JERRY R. MENDELL. “INHIBITION OF MYOSTATIN WITH EMPHASIS ON FOLLISTATIN AS A THERAPY FOR MUSCLE DISEASE.” Muscle and Nerve Science., U.S. National Library of Medicine, 29 Jul. 2009, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717722/.

5 Chaly, Y, et al. “Follistatin-like Protein 1 and Its Role in Inflammation and Inflammatory Diseases.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Aug. 2014, www.ncbi.nlm.nih.gov/pubmed/24838142.

6 Mattiotti, A, et al. “Follistatin-like 1 in Development and Human Diseases.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, July 2018, www.ncbi.nlm.nih.gov/pubmed/29594389.

Leave a Reply